SEC Form 4 · accession 0001652252-18-000013

BIO-RAD LABORATORIES, INC. · BIO BIO.B

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President, and CEO · Director · 10% Owner

Period of report

Sep 4, 2018

Accepted (ET)

Sep 6, 2018 · 3:25 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000012208

Table I — non-derivative securities

Security	Date	Code	Shares	A/D	Owned after	D/I	Nature of ownership
Bio-Rad A Common Stock	holding	—	—	—	411,252	D
Bio-Rad B Common Stock^F1	holding	—	—	—	12,717	I	By Spouse
Bio-Rad B Common Stock^F2	holding	—	—	—	4,060,054	I	By Blue Raven Partners, L.P.
Bio-Rad B Common Stock	holding	—	—	—	256,145	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F3,F4	$0.00	Sep 4, 2018	A	13,000	A	—	—	Bio-Rad A Common Stock	13,000	13,000	D
Non-Qualified Stock Option (right to buy)^F5	$326.15	Sep 4, 2018	A	13,000	A	—	Sep 4, 2028	Bio-Rad A Common Stock	13,000	13,000	D

F1The reporting person disclaims beneficial ownership of these shares.
F2The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F5The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.